Those studies observed a strong association between KRAS mutations, villous component, high-grade dysplasia and polyp size [23, 27–29], which suggested that KRAS mutations might increase the risk of progression in sporadic colorectal adenomas [27, 30]. This evidence concerns the gene KRAS and colorectal adenoma.